Case Challenge

Management of a 56-Year-Old Overweight Hispanic Man With Ribavirin Noncompliance and Lack of SVR on Previous Therapy

Source: Advanced Topics in Hepatitis C Management: Tools for Nurse Practitioners and Physician Assistants

Management of a 56-Year-Old Overweight Hispanic Man With Ribavirin Noncompliance and Lack of SVR on Previous Therapy


CME Program Director: Michael W. Fried, MD

Faculty:

  • Scott Moon, PA-C, MMSc

CME CREDIT INFORMATION

Release Date: 05/07/07

Expiration Date: 05/06/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Physician Assistants: maximum of 1.0 hours of AAPA Category I (Preapproved) credit(s)

Registered Nurses: 1.0 Nursing CE credit

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe strategies for determining duration of therapy by on-treatment response in HCV genotype 1–infected patients
  • Discuss the importance of maintenance of ribavirin dosage and management of anemia during HCV therapy
  • Recount data regarding racial differences in response to HCV therapy
  • Describe the impact of insulin resistance and obesity on response to HCV therapy

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

This program is supported by an independent educational grant provided by

Educational grants support only the CME-certified components of this program.